Jeff Yass’s Inhibrx INBX Stock Holding History

Jeff Yass’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Sell	17,272 -80,601	-82%	-$8.08M	﹤0.01%	6954
2026 Q1	$6.58M	Sell	97,873 -199,243	-67%	-$14.8M	﹤0.01%	3778
2025 Q4	$23.5M	Buy	+297,116	New	+$20.2M	﹤0.01%	2043
2025 Q3	–	Sell	-23,073	Closed	-$568K	–	13114
2025 Q2	$329K	Sell	23,073 -29,800	-56%	-$385K	﹤0.01%	10129
2025 Q1	$740K	Sell	52,873 -19,579	-27%	-$266K	﹤0.01%	8011
2024 Q4	$1.12M	Sell	72,452 -26,917	-27%	-$410K	﹤0.01%	6672
2024 Q3	$1.56M	Sell	99,369 -28,131	-22%	-$395K	﹤0.01%	5819
2024 Q2	$1.81M	Buy	+127,500	New	+$1.99M	﹤0.01%	5296

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's INBX Position: Q2 2026 in Review

Jeff Yass reduced its Inhibrx (INBX) stake by 82% in Q2 2026, selling an estimated $8.08M and leaving 17,272 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #6954.

Jeff Yass first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $23.5M in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

Jeff Yass held 17,272 shares of Inhibrx worth $1.64M as of Q2 2026.
Jeff Yass sold 80,601 Inhibrx shares in Q2 2026, an estimated $8.08M.
Inhibrx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6954 holding.
Jeff Yass first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
Jeff Yass's Inhibrx position peaked at $23.5M in Q4 2025.
163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.